Found: 48
Select item for more details and to access through your institution.
Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseases.
- Published in:
- Alzheimer's Research & Therapy, 2022, p. 1, doi. 10.1186/s13195-022-01122-4
- By:
- Publication type:
- Article
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01087-4
- By:
- Publication type:
- Article
A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39739-5
- By:
- Publication type:
- Article
Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
- Published in:
- Translational Neurodegeneration, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40035-021-00257-y
- By:
- Publication type:
- Article
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 8, p. 1591, doi. 10.1515/cclm-2023-1256
- By:
- Publication type:
- Article
Serum Beta‐Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 1, p. 6, doi. 10.1002/ana.26360
- By:
- Publication type:
- Article
Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9639, doi. 10.3390/ijms23179639
- By:
- Publication type:
- Article
Peptidomic Approaches and Observations in Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7332, doi. 10.3390/ijms23137332
- By:
- Publication type:
- Article
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 2051, doi. 10.3390/ijms23042051
- By:
- Publication type:
- Article
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 19, p. 4674, doi. 10.3390/ijms20194674
- By:
- Publication type:
- Article
Increased NF-L levels in the TDP-43<sup>G298S</sup> ALS mouse model resemble NF-L levels in ALS patients.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 1, p. 161, doi. 10.1007/s00401-022-02436-1
- By:
- Publication type:
- Article
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 1, p. 119, doi. 10.1007/s00401-019-02093-x
- By:
- Publication type:
- Article
Poly- GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/ FTD.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 7, p. 859, doi. 10.15252/emmm.201607486
- By:
- Publication type:
- Article
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration.
- Published in:
- Journal of Neural Transmission, 2022, v. 129, n. 2, p. 207, doi. 10.1007/s00702-021-02411-2
- By:
- Publication type:
- Article
Quantitative mass spectrometry suggests beta‐synuclein as promising blood marker for synaptic degeneration in Alzheimer's disease: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040246
- By:
- Publication type:
- Article
Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 9, p. 996, doi. 10.1016/j.jalz.2016.03.011
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 9, p. 5136, doi. 10.1007/s00415-022-11187-8
- By:
- Publication type:
- Article
Alpha-synuclein is present in dental calculus but not altered in Parkinson’s disease patients in comparison to controls.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 6, p. 1334, doi. 10.1007/s00415-018-8847-2
- By:
- Publication type:
- Article
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 12, p. 2499, doi. 10.1007/s00415-016-8302-1
- By:
- Publication type:
- Article
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 5, p. 954, doi. 10.1007/s00415-016-8094-3
- By:
- Publication type:
- Article
Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 10, p. 1924, doi. 10.1002/acn3.51878
- By:
- Publication type:
- Article
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 10, p. 1904, doi. 10.1002/acn3.51873
- By:
- Publication type:
- Article
CSF Concentrations of cAMP and cGMP Are Lower in Patients with Creutzfeldt-Jakob Disease but Not Parkinson's Disease and Amyotrophic Lateral Sclerosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032664
- By:
- Publication type:
- Article
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.
- Published in:
- Scientific Reports, 2016, p. 38737, doi. 10.1038/srep38737
- By:
- Publication type:
- Article
Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.
- Published in:
- Scientific Reports, 2016, p. 26145, doi. 10.1038/srep26145
- By:
- Publication type:
- Article
CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 4, p. 497, doi. 10.3390/biom10040497
- By:
- Publication type:
- Article
Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 4, p. 2626, doi. 10.1002/ehf2.13986
- By:
- Publication type:
- Article
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
- Published in:
- Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0759-6
- By:
- Publication type:
- Article
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach.
- Published in:
- Molecular Neurodegeneration, 2020, v. 15, n. 1, p. 1, doi. 10.1186/s13024-020-00388-2
- By:
- Publication type:
- Article
Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
- Published in:
- Journal of Neurochemistry, 2016, v. 138, p. 184, doi. 10.1111/jnc.13669
- By:
- Publication type:
- Article
A Review on MS-Based Blood Biomarkers for Alzheimer's Disease.
- Published in:
- Neurology & Therapy, 2019, v. 8, p. 113, doi. 10.1007/s40120-019-00165-4
- By:
- Publication type:
- Article
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.
- Published in:
- Alzheimer's Research & Therapy, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13195-019-0562-4
- By:
- Publication type:
- Article
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.
- Published in:
- Movement Disorders, 2022, v. 37, n. 4, p. 669, doi. 10.1002/mds.28941
- By:
- Publication type:
- Article
Cerebrospinal Fluid Levels of Prodynorphin‐Derived Peptides are Decreased in Huntington's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 2, p. 492, doi. 10.1002/mds.28300
- By:
- Publication type:
- Article
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency.
- Published in:
- Human Molecular Genetics, 2018, v. 27, n. 4, p. 706, doi. 10.1093/hmg/ddx436
- By:
- Publication type:
- Article
Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41398-020-0825-7
- By:
- Publication type:
- Article
Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47765-7
- By:
- Publication type:
- Article
Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 7, p. 4461, doi. 10.1002/alz.13863
- By:
- Publication type:
- Article
The synaptic biomarker contactin5 differentiates between neurodegenerative dementias.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077973
- By:
- Publication type:
- Article
Investigation of plasma β‐synuclein levels in different stages of Alzheimer´s disease and relation to amyloid and tau‐PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074201
- By:
- Publication type:
- Article
Cerebrospinal fluid synaptic biomarkers in AT(N)‐based subgroups of Lewy body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.072253
- By:
- Publication type:
- Article
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein in the differential diagnosis of sporadic Creutzfeldt‐Jakob disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071593
- By:
- Publication type:
- Article
Higher plasma β‐synuclein indicates early synaptic degeneration in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 5095, doi. 10.1002/alz.13103
- By:
- Publication type:
- Article
Blood β‐synuclein is related to amyloid PET positivity in memory clinic patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 4896, doi. 10.1002/alz.13046
- By:
- Publication type:
- Article
High ß‐synuclein plasma levels are coupled with amyloid PET positivity in memory clinic patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.066547
- By:
- Publication type:
- Article
Relationship of serum beta‐synuclein with blood biomarkers and brain atrophy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1358, doi. 10.1002/alz.12790
- By:
- Publication type:
- Article